SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 128 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,005 | +8.1% | 4,463 | +2.1% | 0.01% | +25.0% |
| Q2 2023 | $500,452 | -65.0% | 4,370 | -57.9% | 0.00% | -66.7% |
| Q1 2023 | $1,429,297 | +6.4% | 10,370 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,343,745 | +17.3% | 10,370 | 0.0% | 0.01% | +9.1% |
| Q3 2022 | $1,146,000 | +47.5% | 10,370 | 0.0% | 0.01% | +57.1% |
| Q2 2022 | $777,000 | -4.1% | 10,370 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $810,000 | -13.3% | 10,370 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $934,000 | -2.6% | 10,370 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $959,000 | +19.0% | 10,370 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $806,000 | +4.3% | 10,370 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $773,000 | -56.3% | 10,370 | 0.0% | 0.01% | -58.3% |
| Q4 2020 | $1,768,000 | +21.4% | 10,370 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $1,456,000 | -12.4% | 10,370 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $1,663,000 | +27.1% | 10,370 | -22.4% | 0.01% | +18.2% |
| Q1 2020 | $1,308,000 | -24.2% | 13,370 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $1,725,000 | +71.3% | 13,370 | -0.0% | 0.01% | +57.1% |
| Q3 2019 | $1,007,000 | -50.5% | 13,373 | -0.0% | 0.01% | -50.0% |
| Q2 2019 | $2,033,000 | +27.5% | 13,378 | +0.1% | 0.01% | +27.3% |
| Q1 2019 | $1,594,000 | +9.3% | 13,370 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $1,459,000 | -32.4% | 13,370 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $2,159,000 | -35.6% | 13,370 | -47.3% | 0.01% | -38.1% |
| Q2 2018 | $3,353,000 | +78.4% | 25,370 | 0.0% | 0.02% | +90.9% |
| Q1 2018 | $1,880,000 | +19.1% | 25,370 | -10.6% | 0.01% | +22.2% |
| Q4 2017 | $1,579,000 | +11.0% | 28,370 | -9.6% | 0.01% | +12.5% |
| Q3 2017 | $1,423,000 | +34.6% | 31,370 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $1,057,000 | +13.8% | 31,370 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $929,000 | +8.0% | 31,370 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $860,000 | -55.3% | 31,370 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $1,926,000 | +215.7% | 31,370 | -2.0% | 0.01% | +233.3% |
| Q2 2016 | $610,000 | -2.4% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $625,000 | -49.4% | 32,000 | 0.0% | 0.00% | -57.1% |
| Q4 2015 | $1,235,000 | +20.1% | 32,000 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $1,028,000 | +5.5% | 32,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $974,000 | +129.2% | 32,000 | 0.0% | 0.01% | +150.0% |
| Q1 2015 | $425,000 | -8.2% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $463,000 | -31.4% | 32,000 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $675,000 | -29.2% | 32,000 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $953,000 | +27.9% | 32,000 | +3.2% | 0.00% | +33.3% |
| Q1 2014 | $745,000 | +18.1% | 31,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $631,000 | -56.9% | 31,000 | 0.0% | 0.00% | -57.1% |
| Q3 2013 | $1,464,000 | +3752.6% | 31,000 | +3000.0% | 0.01% | – |
| Q2 2013 | $38,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |